4.8 Article

Maleimide-functionalized closo-dodecaborate albumin conjugates (MID-AC): Unique ligation at cysteine and lysine residues enables efficient boron delivery to tumor for neutron capture therapy

期刊

JOURNAL OF CONTROLLED RELEASE
卷 237, 期 -, 页码 160-167

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jconrel.2016.07.017

关键词

Boron neutron capture therapy (BNCT); Closo-dodecaborate; Albumin modification; Maleimide; Boron delivery system

资金

  1. Ministry of Education, Culture, Sports, Science and Technology, Japan [26293007]
  2. Terumo Foundation for Life Sciences and Arts
  3. Terumo Foundation for Life Science and Art
  4. Cooperative Research Program of Network Joint Research Center for Materials and Devices
  5. Grants-in-Aid for Scientific Research [26293007] Funding Source: KAKEN

向作者/读者索取更多资源

Maleimide-conjugating closo-dodecaborate sodium form 5c (MID) synthesized by the nucleophilic ring-opening reaction of closo-dodecaborate-1,4-dioxane complex 2 with tetrabutylammonium (TBA) azide was found to conjugate to free SH of cysteine and lysine residues in BSA under physiological conditions, forming highly boronated BSA that showed high and selective accumulation in tumor and significant tumor growth inhibition in colon 26 tumor-bearing mice subjected to thermal neutron irradiation. (C) 2016 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据